Efalizumab for subacute cutaneous lupus: report of two different outcomes

Abstract

Get full access to this article

View all access options for this article.

References

Usmani N. , Goodfield M. Efalizumab in the treatment of discoid lupus erythematosus. Arch Dermatol 2007; 143: 873-877.

Clayton TH , Ogden S. , Goodfield MD Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab . J Am Acad Dermatol 2006; 54: 892-895.

Hamprecht A. , Tüting T. , Bieber T. , Wenzel J. Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab. Clin Exp Dermatol 2008; 33: 347-348.

Bentley DD , Graves JE , Smith DI , Heffernan MP Efalizumab-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2006; 54(Suppl. 5): S242-S243.

Heffernan MP , Smith DI , Bentley D. , Tabacchi M. , Graves JE A single-center, open-label, prospective pilot study of subcutaneous efalizumab for oral erosive lichen planus. J Drugs Dermatol 2007; 6: 310-314.

Durox H. , Sparsa A. , Loustaud-Ratti V. , et al. Efalizumab-induced lupus-like syndrome. Acta Derm Venereol 2008; 88: 270-271.